DSG3 and acquired polycythemia vera: Similar to the serology data, we detected Dsg3-specific MBCs in 94% (16/17) of PV patients at the time of diagnosis and 53% (9/17) of the relapse patients, whereas these cells were absent in healthy controls and present in only 20% (2/10) of remission patients (Figure 1C).